SAMPO Sampo Oyj Class A

Sampo Oyj: Johdon liiketoimet (Tetrao SA)

Sampo Oyj: Johdon liiketoimet (Tetrao SA)

SAMPO OYJ                                              JOHDON LIIKETOIMET       23.3.2020 klo 14.00

Sampo Oyj: Johdon liiketoimet (Tetrao SA)

Sampo Oyj (Y-tunnus 0142213-3) on vastaanottanut seuraavan markkinoiden väärinkäyttöasetuksen 19. artiklan mukaisen ilmoituksen.

____________________________________________

Ilmoitusvelvollinen

Nimi: Tetrao SA

Asema: Lähipiiriin kuuluva henkilö

(X) Oikeushenkilö

(1): Liikkeeseenlaskijassa johtotehtävissä toimiva henkilö

Nimi: Björn Wahlroos

Asema: Hallituksen jäsen/varajäsen

Liikkeeseenlaskija: Sampo Oyj

LEI: 743700UF3RL386WIDA22

Ilmoituksen luonne: ENSIMMÄINEN ILMOITUS

Viitenumero: 743700UF3RL386WIDA22_20200323125129_6

____________________________________________

Liiketoimen päivämäärä: 2020-03-23

Kauppapaikka ei sovellu

Instrumenttityyppi: RAHOITUSINSTRUMENTTI, JOKA LIITTYY OSAKKEESEEN TAI VIERAAN PÄÄOMAN EHTOISEEN INSTRUMENTTIIN

ISIN: XS1995716211

Liiketoimen luonne: MUU

Selostus: Arvo-osuustilin panttaus

Liiketoimien yksityiskohtaiset tiedot

(1): Volyymi: 10 000 000 Yksikköhinta: 1 EUR

Liiketoimien yhdistetyt tiedot

(1): Volyymi: 10 000 000 Keskihinta: 1 EUR

____________________________________________

SAMPO OYJ



Jarmo Salonen

Johtaja, sijoittajasuhteet ja konserniviestintä

puh. 010 516 0030

Jakelu:

Nasdaq Helsinki

Lontoon pörssi

Finanssivalvonta

Keskeiset tiedotusvälineet

EN
23/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Sampo Oyj Class A

Håkon Astrup
  • Håkon Astrup

Sampo Oyj (Buy, TP: EUR10.20) - Strong underwriting momentum

Although Q1 PTP declined by 19% YOY to EUR377m, due to a lower investment result, Sampo continued to see strong underwriting momentum, with 9% YOY GWP growth (in local FX) and a 2.5%-points stronger underlying combined ratio YOY. Based on a better synergy outlook from the integration of Topdanmark, it increased its cost improvement guidance. We have raised our 2026–2027e EPS by ~1% on higher growth and ongoing underwriting improvements. We have raised our target price to EUR10.2 (9.8), and reite...

Håkon Astrup
  • Håkon Astrup

Solid growth momentum into 2025e

Helped by benign weather with few storms, we expect solid underwriting across the Nordic P&C sector for Q1, with underlying performance further supported by earned repricing momentum and abating claims inflation. The sector is trading at an attractive average 2026e P/E of c15.2x and we see solid capital distribution prospects. We reiterate our recommendations on all our covered sector names and highlight Tryg as our top pick.

Håkon Astrup
  • Håkon Astrup

Sampo Oyj (Buy, TP: EUR9.80) - Minor model adjustments

We have adjusted our estimates to reflect the now completed 4-to-1 share split announced by the board on 5 February. While we forecast unchanged earnings, we have revised our 2025–2027e EPS and DPS due to the increased share count. We do not consider these changes to be material, and we have not changed our BUY recommendation. We have adjusted our target price to EUR9.80 (49).

Sampo: 1 director

A director at Sampo bought 7,500 shares at 41.097EUR and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing ...

Håkon Astrup
  • Håkon Astrup

Sampo Oyj (Buy, TP: EUR49.00) - Strong underwriting momentum

Against a backdrop of soft financial markets and one-off integration costs, Sampo continues to deliver a solid underwriting performance, with the Q4 adjusted risk ratio improving by 0.3%-points YOY, helped by currency-adjusted GWP growth of 18% YOY. We believe the company’s efforts to mitigate claims inflation and increased frequencies should support growth and earnings, in line with the ambitions from the 2024 CMD, and have raised our 2025–2026e EPS by ~1%. We reiterate our BUY and have raised ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch